Doctoral Program, Department of Psychology, Ariel University, Ariel, Israel.
Adelson School of Medicine, Ariel University, Ariel, Israel.
J Clin Nurs. 2023 Sep;32(17-18):5607-5618. doi: 10.1111/jocn.16653. Epub 2023 Feb 19.
In this study, we systematically reviewed qualitative studies concerning patients' experience with medicinal cannabis (MC) use, to gain insight into the negative effects of MC.
Over the past decades, the use of MC for therapeutic purposes has increased. However, there is conflicting and insufficient data on possible negative physiological and psychological effects of MC treatment.
A systematic review was conducted and the PRISMA guidelines were adopted. Literature searches were conducted using PubMed, PsycINFO and EMBASE. Critical Appraisal Skills Programme (CASP) qualitative checklist used to assess risk of bias in the included studies.
We included studies focusing on conventional medical treatment using cannabis-based products, approved by a physician for a particular health issue.
Of the 1230 articles identified in the initial search, eight articles were included in the review. Following the compilation of themes in the eligible studies, six themes were identified: (1) MC approval; (2) administrative barriers; (3) social perception; (4) MC misuse/widespread effect; (5) adverse effects; and (6) dependence or addiction. These were grouped into two meta-themes: (1) administrative and social aspects of MC use; and (2) experiences of the effects of medicinal cannabis.
Our findings call for specific attention to unique consequences associated with MC use. Further research is needed in order to assess the degree to which negative experiences associated with MC use may affect various aspects of patients' medical condition.
Describing the complex experience of MC treatment and its spectrum of consequences for patients may enable physicians, therapists and researchers to provide more attentive and accurate MC treatment to their patients.
In this review, patients' narratives were explored, yet the research methods did not directly involve patients or the public.
本研究系统回顾了关于患者使用药用大麻(MC)体验的定性研究,以深入了解 MC 的负面影响。
在过去几十年中,出于治疗目的使用 MC 的情况有所增加。然而,关于 MC 治疗可能产生的负面生理和心理影响,目前存在相互矛盾且数据不足的情况。
进行了系统综述,并采用了 PRISMA 指南。使用 PubMed、PsycINFO 和 EMBASE 进行文献检索。使用批判性评估技能计划(CASP)定性清单评估纳入研究的偏倚风险。
我们纳入了专注于使用经医生批准用于特定健康问题的基于大麻的产品进行常规医疗治疗的研究。
在最初的搜索中确定了 1230 篇文章,其中 8 篇文章被纳入综述。在对合格研究中的主题进行编译后,确定了六个主题:(1)MC 批准;(2)行政障碍;(3)社会认知;(4)MC 滥用/广泛影响;(5)不良反应;(6)依赖或成瘾。这些主题被分为两个元主题:(1)MC 使用的行政和社会方面;(2)药用大麻效果的体验。
我们的研究结果呼吁特别关注与 MC 使用相关的独特后果。需要进一步研究,以评估与 MC 使用相关的负面体验可能在多大程度上影响患者医疗状况的各个方面。
描述 MC 治疗的复杂体验及其对患者的后果范围,可能使医生、治疗师和研究人员能够为患者提供更具针对性和准确性的 MC 治疗。
在本次综述中,探讨了患者的叙述,但研究方法并未直接涉及患者或公众。